Transvaginal Sonographic Measurement of Cervical Length Versus Bishop Score in Induction of Labour for Prediction of Caesarean Delivery.
NCT ID: NCT03430804
Last Updated: 2018-02-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
320 participants
OBSERVATIONAL
2017-08-14
2018-01-12
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cervical Length and Bishop Score in Preinduction Cervical Assessment Prior to Induction of Labor
NCT02694315
Bishop Score vs. Cervical Length in Labor Induction
NCT07208552
Value of Measuring Cervical Angle and Length by Ultrasound in Prediction of Successful Induction of Delivery
NCT03113227
Comparison Between Fetal Fibronectin (Ffn) vs Cervical Length in Patient With Unfavourable Cervix in Prediction of Successful Induction of Labor
NCT03925922
Modifying Cervical Bishop Scoring System
NCT02314260
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Study design:
This study is prospective study, comparative clinical trial for a test against a gold standard with blinding of the evaluator
Study setting:
This study will be carried out in Ain-Shams university maternity hospital.
Methods:
* All patients recruited were given an oral consent.
* All patients were subjected to the following:
History of the patient:
* Detailed and careful history was taken from the patient as the following:
1. Personal history: name, age, occupation, residence and special habit of medical importance.
2. Obstetric history: including last menstrual period, Gestation age and regular Antenatal care.
3. Past history: including any medical disorder e.g. Diabetes mellitus, hypertension or any surgical procedure
4. History of present pregnancy: duration of pregnancy from last menstrual period, any complications occurred or any medication used during pregnancy.
Examination of the patient:
<!-- -->
1. General examination: as regard level of consciousness, vital data, and complexion.
2. Abdominal examination: as regard fundal level, lie of the fetus, detection of any uterine contractions and fetal heart rate.
3. Pelvic Examination: as regard pelvic capacity, presenting part, presence of rupture of membranes and cervical assessment as regard cervical dilation, station and presenting part.
* Investigations. Complete blood count , Rh, transvaginal ultra sound and non-stress test.
* All patients had vaginal examination for assessing the (Bishop Score,1964) before induction of labour.
* All women had transvaginal ultrasound for assessment of cervical length using (median digital GAIA) Ultrasonic machine.
Protocol of transvaginal ultrasound will be done as follow:
1. Patient will be asked to void.
2. Vaginal probe will be inserted using direct visualization with K-Y gel.
3. Identification of bladder, amniotic fluid and fetal presenting part.
4. Identification of abnormal findings as placenta pervia or absence of fetal heart motion.
5. Identification of midline sagittal plane of the cervix and looking in the proximal one third of the image for the internal os then pulling back the probe until the lightest touch provides good image of the cervical canal and moving the probe slightly to get the best long axis of the cervix then measuring the cervical length by placing the calipers appropriately and recording the distance between internal and external cervical os.
* Transvaginal ultrasound will be done to assess cervical length using medison sonoace 8800 (median digital GAIA) ultrasound machine equipped with a 7.5 m hertz by vaginal probe in Ain-Shams University Maternity Hospital.
* Induction of labour will be done using intravaginal misoprostol (25 microgram) then digital examination will be made 6 h after the first intravaginal administration; if necessary, 3 doses were given at 6 hours interval. External Cardiotocography will be regularly performed to monitor the condition of the fetus.
* Continuous Cardiotocography will be used in all cases. If necessary, amniotomy will be performed. Intravenous oxytocin administration will be started when there is an arrest of dilatation, starting at 1milli-international unit/minute and increasing 1 mIU every 30 min as necessary. For analgesia, intramuscular pethidine will be offered.
* Caesarean delivery will be done due to pathological fetal heart rate trace, arrest the fetal head for at least one hour despite adequate uterine contractions.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Single gruop320 parturients
Measurement of cervical length and digital examination of Bishop score in 320 women undergoing induction of labour will be carried out in ain shams university maternity hospital.
Bishop score calculation of modified Bishop score in numbers by digital vaginal examination
Measurement of cervical length by transvaginal ultrasound and digital examination of Bishop score in 320 parturients undergoing labour induction at term
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Bishop score calculation of modified Bishop score in numbers by digital vaginal examination
Measurement of cervical length by transvaginal ultrasound and digital examination of Bishop score in 320 parturients undergoing labour induction at term
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
4\. Any medical history contraindicating vaginal delivery. 5. Assessment meconium staining to liquor or any evidence of chorioamnionitis. 6. Previous uterine surgery. 7. Multiple gestations. 8. Women with allergy to prostaglandins.
18 Years
35 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ain Shams University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mohamed Adel Mazroa
Dr resident of obstetrics and gynecology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mohamed adel mazroa
Tanta, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Asu-August 2017
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.